Shire signs $2.1bn loan with core banking group
UK based bio-pharmaceutical company Shire signed a $2.1bn loan last week. The five year loan has two one-year extension options and comprises multi-currency revolving and swingline facilities.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: